Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Expression of girdin in human colorectal cancer and its association with tumor progression.

Jun BY, Kim SW, Jung CK, Cho YK, Lee IS, Choi MG, Choi KY, Oh ST.

Dis Colon Rectum. 2013 Jan;56(1):51-7. doi: 10.1097/DCR.0b013e31826b9b7e.

PMID:
23222280
2.

Expression of protease activated receptor-2 in human colorectal cancer and its association with tumor progression.

Chang JH, Park JM, Kim SW, Jung CK, Kang WK, Oh ST.

Dis Colon Rectum. 2010 Aug;53(8):1202-8. doi: 10.1007/DCR.0b013e3181d536f6.

PMID:
20628286
3.

[Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].

Zhao GP, Zhou ZG, Lei WZ, Wang C, Zheng XL, Zheng YC.

Zhonghua Wei Chang Wai Ke Za Zhi. 2008 Sep;11(5):487-91. Chinese.

PMID:
18803057
4.

Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer.

Oh SY, Kim YB, Suh KW, Paek OJ, Moon HY.

J Surg Res. 2012 Jan;172(1):102-8. doi: 10.1016/j.jss.2010.07.015. Epub 2010 Aug 6.

PMID:
20851411
5.

Girdin, a regulator of cell motility, is a potential prognostic marker for esophageal squamous cell carcinoma.

Shibata T, Matsuo Y, Shamoto T, Hirokawa T, Tsuboi K, Takahashi H, Ishiguro H, Kimura M, Takeyama H, Inagaki H.

Oncol Rep. 2013 Jun;29(6):2127-32. doi: 10.3892/or.2013.2406. Epub 2013 Apr 12.

PMID:
23588413
6.

Tumor deposit is a poor prognostic indicator for patients who have stage II and III colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more.

Nagayoshi K, Ueki T, Nishioka Y, Manabe T, Mizuuchi Y, Hirahashi M, Oda Y, Tanaka M.

Dis Colon Rectum. 2014 Apr;57(4):467-74. doi: 10.1097/DCR.0000000000000059.

PMID:
24608303
7.

Stem cell gene Girdin: a potential early liver metastasis predictor of colorectal cancer.

Liu C, Xue H, Lu Y, Chi B.

Mol Biol Rep. 2012 Sep;39(9):8717-22. doi: 10.1007/s11033-012-1731-8. Epub 2012 Jun 20.

PMID:
22714912
8.

NM23 protein expression in colorectal carcinoma using TMA (tissue microarray): association with metastases and survival.

Oliveira LA, Artigiani-Neto R, Waisberg DR, Fernandes LC, Lima Fde O, Waisberg J.

Arq Gastroenterol. 2010 Oct-Dec;47(4):361-7.

9.

[Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].

Aldrighetti L, Castoldi R, Di Palo S, Arru M, Stella M, Orsenigo E, Gavazzi F, Ferla G, Di Carlo V, Staudacher C.

Chir Ital. 2005 Sep-Oct;57(5):555-70. Italian.

PMID:
16241086
10.

Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.

Karamitopoulou E, Zlobec I, Panayiotides I, Patsouris ES, Peros G, Rallis G, Lapas C, Karakitsos P, Terracciano LM, Lugli A.

Hum Pathol. 2011 Dec;42(12):1888-96. doi: 10.1016/j.humpath.2010.06.020. Epub 2011 Jun 12.

PMID:
21664646
11.

Talen-mediated girdin knockout downregulates cell proliferation, migration and invasion in human esophageal carcinoma ECA109 cells.

Cao K, Jiang W, Cao P, Zou Q, Xiao S, Zhou J, Huang C.

Mol Med Rep. 2014 Aug;10(2):848-54. doi: 10.3892/mmr.2014.2268. Epub 2014 May 26.

PMID:
24865549
12.

Risk factors for residual cancer and lymph node metastasis after noncurative endoscopic resection of early colorectal cancer.

Kim KM, Eo SJ, Shim SG, Chang DK, Kim YH, Rhee PL, Kim JJ, Kim JY.

Dis Colon Rectum. 2013 Jan;56(1):35-42. doi: 10.1097/DCR.0b013e31826942ee.

PMID:
23222278
13.

Factors influencing oncological outcomes in patients who develop pulmonary metastases after curative resection of colorectal cancer.

Kim CH, Huh JW, Kim HJ, Lim SW, Song SY, Kim HR, Na KJ, Kim YJ.

Dis Colon Rectum. 2012 Apr;55(4):459-64. doi: 10.1097/DCR.0b013e318246b08d.

PMID:
22426271
14.

Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.

Pfannschmidt J, Bade S, Hoheisel J, Muley T, Dienemann H, Herpel E.

Thorac Cardiovasc Surg. 2009 Oct;57(7):403-8. doi: 10.1055/s-0029-1185820. Epub 2009 Sep 30.

PMID:
19795327
15.

Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.

Zlobec I, Baker K, Minoo P, Jass JR, Terracciano L, Lugli A.

Clin Cancer Res. 2008 Jan 1;14(1):143-8. doi: 10.1158/1078-0432.CCR-07-1380.

16.

Fascin expression in colorectal carcinomas.

Ozerhan IH, Ersoz N, Onguru O, Ozturk M, Kurt B, Cetiner S.

Clinics (Sao Paulo). 2010 Feb;65(2):157-64. doi: 10.1590/S1807-59322010000200007.

17.

Histopathologic prognostic factors in resected colorectal lung metastases.

Shiono S, Ishii G, Nagai K, Yoshida J, Nishimura M, Murata Y, Tsuta K, Nishiwaki Y, Kodama T, Ochiai A.

Ann Thorac Surg. 2005 Jan;79(1):278-82; discussion 283. Review.

PMID:
15620957
18.
19.

Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.

Nakamura M, Miyamoto S, Maeda H, Zhang SC, Sangai T, Ishii G, Hasebe T, Endoh Y, Saito N, Asaka M, Ochiai A.

Clin Cancer Res. 2004 Dec 15;10(24):8434-41.

20.

Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases.

Park YJ, Park KJ, Park JG, Lee KU, Choe KJ, Kim JP.

World J Surg. 1999 Jul;23(7):721-6.

PMID:
10390594

Supplemental Content

Support Center